Caveolin-1 (Cav-1) is the principal structural component of caveolae organelles in smooth muscle cells, adipocytes, fi broblasts, epithelial cells, and endothelial cells (ECs). Cav-1 -defi cient (Cav-1 knockout [KO]) mice are viable and show increases of nitric oxide (NO) production in vasculature, cardiomyopathy, and pulmonary dysfunction. In this study, we generated EC-specifi c Cav-1 -reconstituted (Cav-1 RC) mice and reexamined vascular, cardiac, and pulmonary phenotypes. Cav-1 KO pulmonary arteries had decreased smooth muscle contractility and increased endothelial NO synthase activation and hypotension; the latter two effects were rescued completely in Cav-1 RC mice. Cav-1 KO mice exhibited myocardial hypertrophy, pulmonary hypertension, and alveolar cell hyperproliferation caused by constitutive activation of p42/44 mitogen-activated protein kinase and Akt. Interestingly, in Cav-1 RC mice, cardiac hypertrophy and pulmonary hypertension were completely rescued, whereas alveolar hyperplasia was partially recovered because of the lack of rescue of Cav-1 in bronchiolar epithelial cells. These results provide clear physiological evidence supporting the important role of cell type -specifi c Cav-1 expression governing multiple phenotypes in the vasculature, heart, and lung. 2374
REGULATION OF PARENCHYMAL FUNCTIONS BY ENDOTHELIAL CAVEOLIN-1 | Murata et al.WT arteries under resting and Ach-stimulated conditions (3 M for 3 min). Again, EC-specifi c Cav-1 RC suppressed this increase in cGMP. In all of the strains, the sensitivity of the soluble guanylyl cyclase was normal because the increases in cGMP production in response to the NO donor sodium nitroprusside (1 M for 3 min) were similar. channels; these eff ects are rescued by breeding global Cav-1 KO to EC-specifi c Cav-1 transgenic (TG) mice ( 15 ) to reconstitute Cav-1 (called Cav-1 RC) back into the endothelium ( 11,16 ). We show that EC-specifi c Cav-1 reconstitution corrects the abnormal vasomotion in vessels and the cardiac and pulmonary abnormalities observed in Cav-1 KO mice, demonstrating that the diverse cardiovascular phenotypes in these mice are attributable to caveolae in the endothelium and not to other cell types that express Cav-1.
RESULTS
Generation of TG mice expressing EC Cav-1 on a Cav-1 -defi cient backgroundTo assess the eff ects of Cav-1/caveolae on vascular, lung, and cardiac phenotypes, mice defi cient in Cav-1 were bred to TG mice expressing Cav-1 in ECs alone, as previously reported ( 11,16 ). Fig. 1 A documents Cav-1 protein expression in intrapulmonary arteries isolated from these mice. WT mice demonstrate the presence of Cav-1 ( Fig. 1 A , left column, green channel) predominantly in the endothelium and lower levels in smooth muscle ( n ϭ 5; Fig. 1 A, top, Cav-1 alone; middle, labeling of smooth muscle ␣ -actin [red] and nuclei [DAPI, blue]; bottom, merged images), whereas Cav-1 KO mice (middle column) lack Cav-1 immunostaining in both layers ( n ϭ 5). Reconstitution of Cav-1 into the endothelium generated by crossing Cav-1 KO...